Antimicrobial prescribing practices in response to different Clostridium difficile diagnostic methodologies

Infect Control Hosp Epidemiol. 2011 Nov;32(11):1133-6. doi: 10.1086/662381. Epub 2011 Sep 29.

Abstract

We evaluated treatment decisions and antimicrobial use related to 2 testing algorithms for Clostridium difficile infection (CDI). Our findings suggest that a 2-step testing algorithm using rapid polymerase chain reaction confirmatory testing leads to decreased unnecessary anti-CDI antimicrobial use. In addition, a significant proportion of patients with confirmed CDI were not treated according to recommended guidelines.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Algorithms
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Proteins / analysis
  • Bacterial Proteins / genetics
  • Bacterial Toxins / analysis
  • Bacterial Toxins / genetics
  • Clostridioides difficile / genetics
  • Clostridioides difficile / isolation & purification*
  • Clostridium Infections / diagnosis*
  • Clostridium Infections / drug therapy*
  • Clostridium Infections / microbiology
  • Decision Making
  • Drug Prescriptions*
  • Enterotoxins / analysis
  • Enterotoxins / genetics
  • Feces / microbiology
  • Female
  • Glutamate Dehydrogenase / analysis
  • Humans
  • Immunoenzyme Techniques
  • Male
  • Metronidazole / therapeutic use
  • Middle Aged
  • Neutralization Tests
  • Polymerase Chain Reaction
  • Practice Patterns, Physicians'*
  • Retrospective Studies
  • Vancomycin / therapeutic use
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Bacterial Toxins
  • Enterotoxins
  • tcdA protein, Clostridium difficile
  • toxB protein, Clostridium difficile
  • Metronidazole
  • Vancomycin
  • Glutamate Dehydrogenase